ClinicalTrials.gg
RecruitingNCT06065384REPAIR-SCIUpdated Dec 12, 2025

Neural Plasticity and Motor Recovery After Upper Extremity Motor Training in People With c-SCI

An interventional study of experimental group: intensive motor training and usual care in Spinal Cord Injuries, sponsored by Annemie Spooren. Recruiting at 4 sites in 2 countries. Open to participants aged 16 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-12-12.

Sponsored by Annemie Spooren · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
16 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Spinal Cord Injuries with a site in Belgium — 6 open to participants now, 6 under way, 1 of them phase 3. Spinal Cord Injuries · Belgium.

Started
2024
with 1 other
No phase
8 of 11
5 open now
Registered
7th of 11
by date
Lead sponsor
1 of 11
Annemie Spooren

Among the 11 studies in Spinal Cord Injuries with a site in Belgium, this one is one of 2 that started in 2024, is one of 8 with no phase, and was the 7th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

6 of the 11 studies in Spinal Cord Injuries with a site in Belgium are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 16 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Spinal Cord Injuries with a site in Belgium, or all of them as a file.
02

Study summary

After spinal cord injury (SCI), there is a disruption in neural circuits resulting in paralysis. There is not yet a cure for paralysis. In persons with Cervical SCI (pwC-SCI) recovery of arm-hand function is very important as it has a significant impact on the patients' level of independence and quality of life. Recovery is assumed to involve alterations in both central and peripheral motor systems. Motor training at an intensive dosage potentially provides a powerful stimulus for neurological recovery. This project exploits the peripheral and central neuroplastic effect of an early (\<13 weeks after injury) and intensive (8 weeks of 6 hours in addition to usual care) upper limb motor training program (EIUMT) directed at recovery below the level of the injury in pwC-SCI within an international multi-center randomized controlled trial including 44 pwC-SCI. It has 4 objectives: to investigate 1)central neural plasticity by identifying alterations in cortical neuroplasticity and corticospinal excitability; 2)peripheral neural plasticity by identifying alterations in axonal excitability and number of motor units; 3)behavioral motor recovery of upper limb and 4)relationships between dose dimensions of motor intervention and behavioral and neurophysiological outcome measures after EIUMT. Cutting-edge neurophysiological measures are used to provide insight in the mechanism of neuroplasticity after EIUMT and will be taken before and after EIUMT and at 6 months follow-up.

Read the detailed description

Background of the study:

Paralysis or paralysis is the most common effect of spinal cord injury (SCI) on individuals. Paralysis affects the ability to walk, perform self-care, live independently and participate in work and leisure activities. In individuals with cervical spinal cord injury, arm and hand function is very important. The most promising and easily implemented intervention that could promote neurological recovery and make a lasting difference in the lives of people with spinal cord injuries is early and intensive motor training aimed at recovery below the injury level. This intervention takes advantage of the early plasticity of the nervous system. By maximizing muscle activation in the first few weeks after injury, we can target the nervous system's unique capacity for neural plasticity where changes can occur in central and peripheral motor systems.

Objective of the study:

This project aims to investigate peripheral and central neuroplasticity following an early (\<13 weeks after injury) and intensive (8 weeks of 6 hours of additional therapy) upper extremity motor training program (EIUMT) aimed at recovery below the lesion level. This project has 4 objectives: to investigate 1) central neural plasticity (identify changes in cortical neuroplasticity and corticospinal excitability; 2) peripheral neural plasticity (identify change in axonal excitability and number of motor units); 3) clinical motor recovery of the upper limbs and 4) relationships between dose dimensions of motor intervention and clinical and neurophysiological outcome measures after EIUMT. Advanced neurophysiological measurements and clinical measurements will be taken before and after EIUMT and at 6-month follow-up.

Study design:

a multicenter pragmatic randomised controlled study in 2 countries

Study population:

44 persons with cervical spinal cord injury (22 participants in the control and intervention groups) Inclusion criteria: Individuals are eligible to participate if they have suffered a traumatic or non-traumatic cervical spinal cord injury within the previous 13 weeks, have AIS (ASIA Impairment Scale) A lesion with motor function more than three levels below motor level (on one or both sides) or have AIS C or AIS D lesion (as defined by the International Standards for the Neurological Classification of spinal cord injury), are older than 16 years of age, have received permission to begin rehabilitation and are likely to remain an inpatient for the next 8 weeks.

Exclusion criteria: Participants will be excluded if they have a significant medical or physical condition or psychiatric illness that could prevent the person from participating in the study or would place the person at unacceptable risk if they were to participate.

Intervention:

The intervention group receives 6 hours of motor training each week. This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.

The control group receives only standard rehabilitation and care.

Primary study parameters/outcome of the study (Baseline vs 8 weeks after randomisation):

Central plasticity via: Single pulse TMS (transcranial magnetic stimulation) (Resting Motor Threshold) Peripheral plasticity via: Peripheral nerve assessment (Compound muscle action potential (CMAP)) Functional recovery via: Grades redefined assessment of strength, sensibility and Prehension (GRASSP)

Secondary study parameters/outcome of the study:

Clinical Measures: Upper Extremity Motor Score, Spinal Cord Independence Measure (SClM-selfcare); Van Lieshout Test (VLT); Hand-Held Dynamometry; accelerometry (session density: active therapy time/session length); perceived difficulty and exertion) Central plasticity: Single Pulse TMS: Stimulus-Response Function, Cortical mapping, Paired pulse TMS: SICI (short interval intracortical inhibition); LICI (long interval intracortical inhibition) Peripheral plasticity: NET (Nerve excitability testing) and MScanFit MUNE.

03

Conditions studied

  • Spinal Cord Injuries

Keywords

  • spinal cord rehabilitation
  • therapy dose
  • neural plasticity
  • motor recovery
  • upper limb training
04

Who can participate

Ages eligible
16 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Traumatic or non-traumatic C-SCI in the preceding 13 weeks; age over 16 years; have an incomplete SCI categorized as AIS C or D or an AIS A SCI with zones of partial motor paralysis (as defined by the International Standards for the Neurological Classification of SCI (ISNCI) and medically stable.

Exclusion criteria

Exclusion Criteria:

  • SCI with ASIA Impairment Scale (AIS) A without zones of partial preservation (decided based on former studies) and expertise of the team; SCI with any significant medical condition that could prevent the person from participating. Patients will be excluded from the measures of central plasticity in the presence of for TMS application such as epilepsy, metal implants in the brain, defibrillator, pacemaker, and pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    intensive upper limb training

    The intervention group receives 6 hours of motor training each week upon usual care during 8 weeks. This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.

    Other: experimental group: intensive motor training

  • Other
    usual care

    The control group receives only standard rehabilitation and care

    Other: usual care

Interventions

  • Otherexperimental group: intensive motor training

    Intervention group: receive an extra 6 hours of motor training each week (distributed over the week) for 8 weeks. It will involve active and targeted motor training of all affected muscles of the upper limb below the level of the injury within the context of practice of functional activities. Interventions will be goal directed and individualized to the needs of each participant with a focus on training that addresses each person's specific motor problem, promoting motor learning as well as stimulating neural plasticity. All patients will continue to receive usual physiotherapy and usual rehabilitation.

  • Otherusual care

    usual rehabilitation

06

What researchers measure

Primary outcomes

  1. changes in single pulse TMS: resting motor threshold

    to asses changes in cortical reactivity

    Time frame: - before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up

  2. Changes in Compound Muscle Action Potential (CMAP)

    Changes in amplitude of CMAP

    Time frame: - before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up

  3. changes in GRASSP

    Grades redefined assessment of strength sensibility and Prehension

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

Secondary outcomes

  1. Single-pulse TMS: Stimulus Response Curve

    \- to assess cortical excitability

    Time frame: - before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up

  2. changes SICI

    to evaluatie changes in Short interval intracortical inhibition

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  3. changes in LICI

    long-interval intracortical inhibition

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  4. changes in MscanFit MUNE

    Compound muscle action potential (CMAP) scans will be recorded

    Time frame: - before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up

  5. changes in single pulse TMS: mapping

    to evaluate changes in cortical reorganisation

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  6. changes in NET (Nerve excitability testing)

    Stimulus-Response Curve, Strength duration time constant (SDTC), threshold electrotonus (TE), I/V relationship (I/V) and recovery cycles (RC) will be measured.

    Time frame: - before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up

  7. changes in behavioral measures: Upper extremity motor score

    score on 50

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  8. changes in Spinal Cord independence Measures

    questionaire: self-care score

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  9. changes in Van Lieshout Test

    basis upper extremity skills

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  10. changes in hand held dynamometry

    strength in hand

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

  11. Goal satisfaction

    Subjective scoring 0-10 of four goals

    Time frame: - before intervention; at 8 weeks (after intervention) and at 6 months follow-up

Other outcomes

  1. Subjectively perceived session difficulty

    VAS

    Time frame: measurement of one week during the 2., 5. and 8. week of intervention duration; before and after completion of session

  2. Objective active time

    accelerometry

    Time frame: - measurement of one week during the 2., 5. and 8. week of intervention duration

  3. Subjectively perceived session intensity

    VAS (perceived exertion)

    Time frame: measurement of one week during the 2., 5. and 8. week of intervention duration; before and after completion of session

  4. Therapy documentation

    Total session length and UL training session length based on therapy documentation

    Time frame: whole trial period of 8 weeks

07

Study locations

3 of 4 sites recruiting
  • Revalidatieziekenhuis RevArte
    Antwerp, 2650, Belgium
    Recruiting
  • UZGent
    Ghent, Belgium
    Recruiting
    • Kristine Oostra, Prof. Dr. · Contact
  • UZLeuven Campus Pellenberg
    Leuven, Belgium
    Not yet recruiting
    • Koen Peers, Prof. Dr. · Contact
  • Zorggroep Adelante
    Hoensbroek, Netherlands
    Recruiting
    • Charlotte Van Laake, dr. · Contact
08

References and documents

Publications

  • Hrycyk IJ, Bertels N, Tankisi H, Glinsky JV, Oostra K, van Laake-Geelen C, Tedesco Triccas L, Spooren A. Central and peripheral neuroplasticity in cervical spinal cord injury following intensive upper limb motor training: a randomised controlled trial protocol. BMJ Open. 2026 Mar 18;16(3):e107352. doi: 10.1136/bmjopen-2025-107352. PubMed 41857841 ↗

Individual participant data

Plan to share: Yes — Pseudomised data will be discussed with Aarhus University because they will assist in data analyses. The protocol will be shared with the partners (Aarhus University, Sydney University, UZ Gent, UZ Leuven, RZ RevArte, and Adelante Zorggroep)

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: during and after data gathering

Access criteria: only for collaborating partners

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Mar 2027, 29 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 29 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2023
First posted
Oct 3, 2023
StartActual
Oct 9, 2024
Primary completionEst.
Mar 28, 2027
CompletionEst.
Aug 28, 2027
Last update
Dec 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06065384
Lead sponsor
Annemie Spooren
Collaborators
Research Foundation Flanders, University of Aarhus, University of Sydney, University Hospital, Ghent, Universitaire Ziekenhuizen KU Leuven, Adelante, Centre of Expertise in Rehabilitation and Audiology, Rehabilitation Hospital RevArte
Responsible party
Annemie Spooren (Prof. Annemie Spooren, Hasselt University) — Sponsor-investigator
First posted
Oct 3, 2023
Start date
Oct 9, 2024
Primary completion
Mar 28, 2027 (estimated)
Completion
Aug 28, 2027 (estimated)
Last update
Dec 12, 2025

Study contacts

Annemie Spooren, Prof. Dr.
Contact
annemie.spooren@uhasselt.be
11269332
Lisa Tedesco Triccas, Prof. Dr.
Contact
lisa.tedescotriccas@uhasselt.be
Annemie Spooren, Prof. Dr.
principal investigator · Hasselt University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion